Ritalin / Methylphenidate
Ritalin - Concerta - Equasym - Medikinet - Xenidateplease click on each drug name above to connect to UK drug data sheets Active Substance - Methylphenidate Indication - Treatment of Attention-Deficit/Hyperactivity Disorder (ADHD) The United States drug regulator, the FDA has identified two possible safety concerns with the methylphenidate drug products: psychiatric adverse events and cardiovascular adverse events -
Statement on Concerta and Methylphenidate for the FDA Pediatric Advisory Committee - June 30, 2005 Reporting adverse side effects Please submit a Yellow Card report to the regulator (MHRA) in the UK or to the medicines regulator in your own country. The US FDA accept reports from any country. The independent www.rxisk.org web site also accept worldwide reports and provide additional information based on FDA statistics. Be aware of interactions with other medicines.. Reporting Adverse Drug Reactions (ADRs) Please report Adverse Drug Reactions (ADRs) to: UK Yellow Card Reporting for Patient and Health Professional reports of Adverse Drug Reactions USA and worldwide to the Food and Drug Administration for Patients and Healthcare Professionals Universal free, independent drug safety website - Rxisk Please follow APRIL on Twitter For latest news read the APRIL blog
AWARENESS SAVES LIVES
|